[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
[2]BOKHMAN JV.Two pathogenetic types of endometrial carcinoma[J].Gynecol Oncol,1983,15(1):10-17.
[3]ZHANG L,WAN Y,ZHANG Z,et al.FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway[J].RNA Biol,2021,18(9):1265-1278.
[4]AMANT F,MOERMAN P,NEVEN P,et al.Endometrial cancer[J].Lancet,2005,366(9484):491-505.
[5]CLAUDE HERVE J,DHEIN S.Peptides targeting gap junctional structures[J].Curr Pharm Des,2010,16(28):3056-3070.
[6]SAITO T,NISHIMURA M,KUDO R,et al.Suppressed gap junctional intercellular communication in carcinogenesis of endometrium[J].Int J Cancer,2001,93(3):317-323.
[7]TROSKO JE.On the potential origin and characteristics of cancer stem cells[J].Carcinogenesis,2021,42(7):905-912.
[8]FATTAHI S,AMJADI-MOHEB F,TABARIPOUR R,et al.PI3K/AKT/mTOR signaling in gastric cancer:Epigenetics and beyond[J].Life Sci,2020,262:118513.
[9]MIRICESCU D,TOTAN A,STANESCU-SPINU II,et al.PI3K/AKT/mTOR signaling pathway in breast cancer:from molecular landscape to clinical aspects[J].Int J Mol Sci,2020,22(1):173.
[10]TAN AC.Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)[J].Thorac Cancer,2020,11(3):511-518.
[11]CHE Y,LI Y,ZHENG F,et al.TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK,PI3K/AKT,and hTERT signaling[J].Cancer Lett,2019,452:1-13.
[12]PONTES HAR,PONTESONTES FSC,DE JESUS AS,et al.p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma:an immunohistochemical study[J].J Oral Pathol Med,2015,44(7):532-537.
[13]WANG H,LI M,TAO X,et al.ARHGEF39 promotes gastric cancer cell proliferation and migration via Akt signaling pathway[J].Mol Cell Biochem,2018,440:33-42.
[14]谢梅青,邝健全.子宫内膜间隙连接通讯研究进展[J].广东医学,2002,23(5):546-548.
XIE MQ,KUANG JQ.Research progress in endometrial space connection communication[J].Guangdong Medical Journal,2002,23(5):546-548.
[15]MESNIL M,KRUTOVSKIKH V,PICCOLI C,et al.Negative growth control of HeLa cells by connexin genes:connexin species specificity[J].Cancer Res,1995,55(3):629-639.
[16]ZHANG Y,TAO L,FAN L,et al.Different gap junction-propagated effects on cisplatin transfer result in opposite responses to cisplatin in normal cells versus tumor cells[J].Sci Rep,2015,5(1):12563.
[17]XIANG Y,WANG Q,GUO Y,et al.Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2019,38(1):1-15.
[18]WINCEWICZ A,BALTAZIAK M,KANCZUGA-KODA L,et al.Aberrant distributions and relationships among E-cadherin,β-catenin,and connexin 26 and 43 in endometrioid adenocarcinomas[J].Int J Gynecol Pathol,2010,29(4):358-365.
[19]SAITO T,TANAKA R,WATABA K,et al.Overexpression of estrogen receptor-α gene suppresses gap junctional intercellular communication in endometrial carcinoma cells[J].Oncogene,2004,23(5):1109-1116.
[20]UGUR D,GUNGUL TB,YUCEL S,et al.Connexin 32 overexpression increases proliferation,reduces gap junctional intercellular communication,motility and epithelial-to-mesenchymal transition in Hs578T breast cancer cells[J].J Cell Commun Signal,2022,16(3):361-376.
[21]ANNOVAZZI L,MELLAI M,CALDERA V,et al.mTOR,S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma[J].Anticancer Res,2009,29(8):3087-3094.
[22]徐利本,吴朝阳,王远东.PI3K/Akt信号传导通路在肿瘤发生发展及治疗中的作用[J].现代肿瘤医学,2021,29(01):177-180.
XU LB,WU CY,WANG YD.The role of PI3K/Akt signal pathway in the development and progression of tumor[J].Modern Oncology,2021,29(01):177-180.
[23]HOXHAI G,MANNING BD.The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism[J].Nat Rev Cancer,2020,20(2):74-88.
[24]DENG J,BAI X,FENG X,et al.Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression[J].BMC Cancer,2019,19(1):1-12.
[25]LI H,WANG B,QI B,et al.Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway[J].Oncol Rep,2022,48(3):1-12.
[26]YU B,LIU L,YAN J,et al.Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism[J].Anticancer Drugs,2022,33(1):178-185.